| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/04/2004 | WO2003054018A3 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 03/04/2004 | WO2003054006A3 Mutated hiv tat |
| 03/04/2004 | WO2003053463A3 Poxvirus-containing compositions and process for their preparation |
| 03/04/2004 | WO2003052122A3 Gp41 inhibitor |
| 03/04/2004 | WO2003051914A3 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003048301A3 Anti-hla-dr antibodies and the methods of using thereof |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003043574A3 Pharmaceutical compositions in particulate form |
| 03/04/2004 | WO2003039466A8 Method of treating estrogen responsive breast cancer |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses |
| 03/04/2004 | WO2003007986A3 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2003000310A9 Nasal devices |
| 03/04/2004 | WO2002102971A3 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 03/04/2004 | WO2002092818A8 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002072606A3 Epitope testing using hla |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044193 C. albicans tec1 gene (catec1) and the coded tecip protein |
| 03/04/2004 | US20040044192 Genetic engineered polypeptide; diagnosis of Lyme disease |
| 03/04/2004 | US20040044183 Peptide inhibitors of HIV entry |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043931 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043456 Novel compounds |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043040 SDF-1 beta tumor vaccines and uses therefor |
| 03/04/2004 | US20040043039 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsides |
| 03/04/2004 | US20040043038 Vaccines |
| 03/04/2004 | US20040043037 Staphylococcus aureus polynucleotides and sequences |
| 03/04/2004 | US20040043035 Recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 03/04/2004 | US20040043034 Collectins as adjuvants |
| 03/04/2004 | US20040043033 Method and vaccine for the prevention of AIDS |
| 03/04/2004 | US20040043032 Vaccine |
| 03/04/2004 | US20040043003 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 03/04/2004 | US20040042971 Spray freeze dry of compositions for pulmonary administration |
| 03/04/2004 | CA2536254A1 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | CA2496750A1 Vaccine for respiratory and reproductive system infections in cattle |
| 03/04/2004 | CA2496686A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | CA2496572A1 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496422A1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | CA2496384A1 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496242A1 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | CA2495849A1 Ptk7 protein involvement in carcinoma |
| 03/04/2004 | CA2495546A1 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/04/2004 | CA2494806A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394259A2 Recombinant infectious non-segmented negative strand RNA virus |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394254A1 Method of producing antigens, antigens and their use |
| 03/03/2004 | EP1394253A1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1393746A1 Human polyclonal antibody compositions |
| 03/03/2004 | EP1393744A1 Acellular pertussis vaccines and methods of preparation thereof |
| 03/03/2004 | EP1393743A1 Agents modulating UPA/UPAR activity for the treatment of AIDS |
| 03/03/2004 | EP1393723A2 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392728A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392361A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392358A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392356A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392341A2 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 03/03/2004 | EP1392330A1 Use of lps for treating intestinal inflammation processes |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392305A2 Methods for treating neurodegenerative diseases including alzheimer's |